{"id":54973,"date":"2023-03-20T11:05:02","date_gmt":"2023-03-20T10:05:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/"},"modified":"2023-03-20T11:05:02","modified_gmt":"2023-03-20T10:05:02","slug":"vizient-to-share-insights-on-biosimilars-at-festival-of-biologics","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/","title":{"rendered":"Vizient to Share Insights on Biosimilars at Festival of Biologics"},"content":{"rendered":"<div>\n<p>IRVING, Texas&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vizientinc.com%2F&amp;esheet=53363886&amp;newsitemid=20230320005137&amp;lan=en-US&amp;anchor=Vizient%2C+Inc.&amp;index=1&amp;md5=58f5b04402ff18c63cfb672e84e919ba\" rel=\"nofollow noopener\" shape=\"rect\">Vizient, Inc.<\/a> announced today that <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnewsroom.vizientinc.com%2Fen-US%2Freleases%2Fsteven-lucio-pharmd-bcps&amp;esheet=53363886&amp;newsitemid=20230320005137&amp;lan=en-US&amp;anchor=Steven+Lucio&amp;index=2&amp;md5=8cbb9b18028c5508e347399cf74eb5ec\" rel=\"nofollow noopener\" shape=\"rect\">Steven Lucio<\/a>, PharmD, BCPS, senior principal, pharmacy solutions for Vizient, will share insights on biosimilars in the panel discussion, \u201cBuilding the Sustainable Future of Biosimilars,\u201d at the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.terrapinn.com%2Fconference%2Ffestival-of-biologics-usa%2Findex.stm&amp;esheet=53363886&amp;newsitemid=20230320005137&amp;lan=en-US&amp;anchor=Festival+of+Biologics&amp;index=3&amp;md5=70c57828d6d560b0daba731d809906fa\" rel=\"nofollow noopener\" shape=\"rect\">Festival of Biologics<\/a> being held March 20-22 in San Diego.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230320005137\/en\/637378\/5\/Vizient_Logo_V2.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230320005137\/en\/637378\/21\/Vizient_Logo_V2.jpg\"><\/a><\/p>\n<p>\nLucio, who has <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.amazon.com%2FBiosimilars-Biologics-Implementation-Monitoring-Healthcare%2Fdp%2F1585285803%2Fref%3Dsr_1_2%3Fdchild%3D1%26keywords%3Dsteven%2Blucio%2Bbiosimilars%26qid%3D1632163901%26sr%3D8-2&amp;esheet=53363886&amp;newsitemid=20230320005137&amp;lan=en-US&amp;anchor=extensive+expertise+in+biosimilars&amp;index=4&amp;md5=df63f14a245db7831abc560ac872eccd\" rel=\"nofollow noopener\" shape=\"rect\">extensive expertise in biosimilars<\/a>, educates healthcare organizations on the benefits of biosimilars and helps them develop strategies to include them in patient care. Last year he led a team that <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnewsroom.vizientinc.com%2Fen-US%2Freleases%2Fnew-survey-from-vizient-provides-hospital-insights-into-biosimilar-adoption-and-what-is-preventing-greater-utilization&amp;esheet=53363886&amp;newsitemid=20230320005137&amp;lan=en-US&amp;anchor=conducted+a+survey&amp;index=5&amp;md5=00fc07899c4d5179cbf6c8bc4a7fe607\" rel=\"nofollow noopener\" shape=\"rect\">conducted a survey<\/a> of hospital leaders and pharmacy professionals from across the country that found biosimilars are gaining inclusion in hospital formularies, something long seen as a necessity for greater adoption.\n<\/p>\n<p>\n\u201cVizient continues to advocate for biosimilar adoption to create more competition in the market,\u201d Lucio said. \u201cBiosimilars are as effective as their originator biologic counterparts and represent an opportunity that, when fully optimized, can lower costs without compromising the quality of patient care.\u201d\n<\/p>\n<p>\nThe panel discussion \u201cBuilding the Sustainable Future of Biosimilars,\u201d will take place on March 21 at 4:40 p.m. PDT.\n<\/p>\n<p>\n<b>About Vizient, Inc.<\/b>\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnewsroom.vizientinc.com%2F&amp;esheet=53363886&amp;newsitemid=20230320005137&amp;lan=en-US&amp;anchor=Vizient%2C+Inc&amp;index=6&amp;md5=2c96d92ed288d0a41675b0c541e9936e\" rel=\"nofollow noopener\" shape=\"rect\">Vizient, Inc<\/a>., the nation\u2019s largest health care performance improvement company, serves more than 60% of the nation\u2019s acute care providers, which includes 97% of the nation\u2019s academic medical centers, and more than 25% of the non-acute market. Vizient provides expertise, analytics and advisory services, as well as a contract portfolio that represents more than $130 billion in annual purchasing volume. Vizient\u2019s solutions and services improve the delivery of high-value care by aligning cost, quality and market performance. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vizientinc.com&amp;esheet=53363886&amp;newsitemid=20230320005137&amp;lan=en-US&amp;anchor=www.vizientinc.com&amp;index=7&amp;md5=e9b4fbd4956c01e008ed3574e6467c3b\" rel=\"nofollow noopener\" shape=\"rect\">www.vizientinc.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nDonna Ledbetter<br \/>\n<br \/>(972) 830-6321<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;&#58;&#100;onn&#x61;&#x2e;&#x6c;&#x65;&#x64;&#98;&#101;&#116;ter&#x40;&#x76;&#x69;&#x7a;&#x69;&#101;&#110;&#116;inc&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x64;o&#x6e;&#110;&#x61;&#46;&#x6c;&#x65;d&#x62;&#101;&#x74;&#116;&#x65;&#114;&#64;&#x76;&#105;&#x7a;&#105;&#x65;&#110;t&#x69;&#110;&#x63;&#46;&#x63;&#111;m<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVING, Texas&#8211;(BUSINESS WIRE)&#8211;Vizient, Inc. announced today that Steven Lucio, PharmD, BCPS, senior principal, pharmacy solutions for Vizient, will share insights on biosimilars in the panel discussion, \u201cBuilding the Sustainable Future of Biosimilars,\u201d at the Festival of Biologics being held March 20-22 in San Diego. Lucio, who has extensive expertise in biosimilars, educates healthcare organizations on &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54973","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vizient to Share Insights on Biosimilars at Festival of Biologics - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vizient to Share Insights on Biosimilars at Festival of Biologics - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"IRVING, Texas&#8211;(BUSINESS WIRE)&#8211;Vizient, Inc. announced today that Steven Lucio, PharmD, BCPS, senior principal, pharmacy solutions for Vizient, will share insights on biosimilars in the panel discussion, \u201cBuilding the Sustainable Future of Biosimilars,\u201d at the Festival of Biologics being held March 20-22 in San Diego. Lucio, who has extensive expertise in biosimilars, educates healthcare organizations on ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-20T10:05:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230320005137\/en\/637378\/21\/Vizient_Logo_V2.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Vizient to Share Insights on Biosimilars at Festival of Biologics\",\"datePublished\":\"2023-03-20T10:05:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/\"},\"wordCount\":286,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005137\\\/en\\\/637378\\\/21\\\/Vizient_Logo_V2.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/\",\"name\":\"Vizient to Share Insights on Biosimilars at Festival of Biologics - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005137\\\/en\\\/637378\\\/21\\\/Vizient_Logo_V2.jpg\",\"datePublished\":\"2023-03-20T10:05:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005137\\\/en\\\/637378\\\/21\\\/Vizient_Logo_V2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005137\\\/en\\\/637378\\\/21\\\/Vizient_Logo_V2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vizient to Share Insights on Biosimilars at Festival of Biologics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vizient to Share Insights on Biosimilars at Festival of Biologics - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/","og_locale":"en_US","og_type":"article","og_title":"Vizient to Share Insights on Biosimilars at Festival of Biologics - Pharma Trend","og_description":"IRVING, Texas&#8211;(BUSINESS WIRE)&#8211;Vizient, Inc. announced today that Steven Lucio, PharmD, BCPS, senior principal, pharmacy solutions for Vizient, will share insights on biosimilars in the panel discussion, \u201cBuilding the Sustainable Future of Biosimilars,\u201d at the Festival of Biologics being held March 20-22 in San Diego. Lucio, who has extensive expertise in biosimilars, educates healthcare organizations on ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-20T10:05:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230320005137\/en\/637378\/21\/Vizient_Logo_V2.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Vizient to Share Insights on Biosimilars at Festival of Biologics","datePublished":"2023-03-20T10:05:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/"},"wordCount":286,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230320005137\/en\/637378\/21\/Vizient_Logo_V2.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/","url":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/","name":"Vizient to Share Insights on Biosimilars at Festival of Biologics - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230320005137\/en\/637378\/21\/Vizient_Logo_V2.jpg","datePublished":"2023-03-20T10:05:02+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230320005137\/en\/637378\/21\/Vizient_Logo_V2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230320005137\/en\/637378\/21\/Vizient_Logo_V2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vizient-to-share-insights-on-biosimilars-at-festival-of-biologics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Vizient to Share Insights on Biosimilars at Festival of Biologics"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54973"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54973\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}